Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

9.220 +0.160 (+1.77%)
Streaming Delayed Price Updated: 12:05 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Adma Biologics

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company... 
Via Benzinga
ADMA Biologics Inc (ADMA) Q2 2021 Earnings Call Transcript
ADMA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Why Is It Moving? Looking At ADMA Biologics's Price Action Today
ADMA Biologics's Stock Price And Volume Action ADMA Biologics's (NASDAQ: 
Via Benzinga
ADMA Biologics Breaks Downtrend And May Rally
After a painful two months, shareholders of ADMA Biologics (NASDAQ:ADMA) may final... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $775 to $950. NVIDIA shares rose 0.6% to $824.60 in pre-market trading. Goldman Sachs boosted American... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead of Manufacturing Data
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones gained 65 points in the previous session. Markets were closed Monday for the... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Stocks To Watch For June 1, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Hewlett Packard Enterprise Co (NYSE: HPE) to post quarterly earnings at $0.42 per share on revenue... 
Via Benzinga
ROCE Insights For ADMA Biologics
During Q1, ADMA Biologics (NASDAQ:ADMA) brought in sales totaling $16.05 million. However, earnings decreased 11.94%, resulting in a loss of $15.16 million. In Q4, ADMA Biologics... 
Via Benzinga
ADMA Biologics Inc (ADMA) Q1 2021 Earnings Call Transcript
ADMA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: ADMA Biologics Q1 Earnings
Shares of ADMA Biologics (NASDAQ:ADMA) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 38.46% over the... 
Via Benzinga
ADMA Biologics Earnings Preview
On Wednesday, May 12, ADMA Biologics (NASDAQ:ADMA) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.... 
Via Benzinga
ADMA Stock: The Big FDA News Boosting ADMA Biologics Today
Today, ADMA stock is a big mover as the company announced a very bullish FDA approval allowing the company to scale its core product. 
Via InvestorPlace
Exposures Product Safety
ADMA Biologics Shares Jump On Increased Manufacturing Capacity For Intravenous Immune Globulin
The FDA has approved ADMA Biologics Inc's (NASDAQ: ADMA) expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.